
Prostate specific antigen is the "gold standard" prostate tissue marker. Based on a reviews of the literature, we present the metabolism, method and lassay clinical use for diagnosis, staging and prostate cancer as well as for monitoring response to treatment. The authors also discuss some situations able to increase the level of this marker.
Adult, Male, Age Factors, Prostatic Neoplasms, Reproducibility of Results, Middle Aged, Prostate-Specific Antigen, Prognosis, Bias, Reference Values, Biomarkers, Tumor, Humans, Mass Screening, Aged, Neoplasm Staging
Adult, Male, Age Factors, Prostatic Neoplasms, Reproducibility of Results, Middle Aged, Prostate-Specific Antigen, Prognosis, Bias, Reference Values, Biomarkers, Tumor, Humans, Mass Screening, Aged, Neoplasm Staging
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
